AMGN Competitors & Alternatives
Compare Amgen Inc with similar stocks in the same industry
Drug Manufacturers - General
AMGN
Main Stock$336.23
Tradestie Score
57
Market Cap
$160.70B
P/E Ratio
23.4
Revenue Growth
0.1%
Analyst Upside
+5.0%
Top Competitors
16 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$45.80
|
$262.92B | 10.7 | 59 | Compare |
|
AZN
AstraZeneca PLC
|
$184.96
|
$261.56B | 27.9 | 52 | Compare |
|
NVS
Novartis AG
|
$149.77
|
$254.99B | 21.5 | 60 | Compare |
|
MRK
Merck & Co., Inc.
|
$113.41
|
$225.13B | 32.0 | 63 | Compare |
|
PFE
Pfizer Inc.
|
$25.75
|
$154.70B | 19.8 | 59 | Compare |
|
GILD
Gilead Sciences Inc
|
$132.06
|
$137.92B | 18.1 | 60 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.85
|
$121.27B | 18.3 | 56 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$56.77
|
$96.54B | 15.8 | 56 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$50.96
|
$91.59B | 13.2 | 53 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$191.37
|
$22.61B | 22.0 | 63 | Compare |
More AMGN Analysis
Data updated: May 14, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
16 stocks in this industry